[Türkçe]

Turkish Society of Cardiology Young Cardiologists Bulletin Year: 8 Number: 4 / 2025


Turkish Society of Cardiology
Young Cardiologists
President
Dr. Muzaffer Değertekin

Coordinator for the
Board of Directors

Dr. Ertuğrul Okuyan

Coordinator for the
Board of Directors

Dr. Can Yücel Karabay

Members
Dr. Adem Aktan
Dr. Gülşah Aktüre
Dr. Bayram Arslan
Dr. İnanç Artaç
Dr. Ahmet Oğuz Aslan
Dr. Görkem Ayhan
Dr. Ahmet Anıl Başkurt
Dr. Özkan Bekler
Dr. Oğuzhan Birdal
Dr. Yusuf Bozkurt Şahin
Dr. Serkan Bulgurluoğlu
Dr. Ümit Bulut
Dr. Veysi Can
Dr. Mustafa Candemir
Dr. Murat Çap
Dr. Göksel Çinier
Dr. Ali Çoner
Dr. Yusuf Demir
Dr. Ömer Furkan Demir
Dr. Murat Demirci
Dr. Ayşe İrem Demirtola Mammadli
Dr. Süleyman Çağan Efe
Dr. Mehmet Akif Erdöl
Dr. Kubilay Erselcan
Dr. Kerim Esenboğa
Dr. Duygu Genç
Dr. Kemal Göçer
Dr. Elif Güçlü
Dr. Arda Güler
Dr. Duygu İnan
Dr. Hasan Burak İşleyen
Dr. Muzaffer Kahyaoğlu
Dr. Sedat Kalkan
Dr. Yücel Kanal
Dr. Özkan Karaca
Dr. Ahmet Karaduman
Dr. Mustafa Karanfil
Dr. Ayhan Kol
Dr. Fatma Köksal
Dr. Mevlüt Serdar Kuyumcu
Dr. Yunus Emre Özbebek
Dr. Ahmet Özderya
Dr. Yasin Özen
Dr. Ayşenur Özkaya İbiş
Dr. Çağlar Özmen
Dr. Selvi Öztaş
Dr. Hasan Sarı
Dr. Serkan Sivri
Dr. Ali Uğur Soysal
Dr. Hüseyin Tezcan
Dr. Nazlı Turan
Dr. Berat Uğuz
Dr. Örsan Deniz Urgun
Dr. İdris Yakut
Dr. Mustafa Yenerçağ
Dr. Mehmet Fatih Yılmaz
Dr. Yakup Yiğit
Dr. Mehmet Murat Yiğitbaşı


 


Turkish Society of Cardiology Young Cardiologists Bulletin / "TSCYOUNG" Eylül 2025 (4)
Issue Summary
ALONE-AF: Discontinuing Long-Term Oral Anticoagulation After Successful Atrial Fibrillation Ablation
Dr. Abdalrahman Shawky A. Mostafa, Dr. Mustafa Yenerçağ

BEAT PAROX AF: A Randomized Comparison of PFA vs. RFA
Dr. Abdalrahman Shawky A. Mostafa, Dr. Mustafa Yenerçağ

ABC-AF study - a randomised controlled study of personalised treatment to reduce stroke or death in atrial fibrillation
Dr. Emre Kipritçi

HI-PRO: Apixaban for Extended Treatment of Provoked Venous Thromboembolism
Dr. Emre Kipritçi

SWEDEPAD-1 (Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia) & SWEDEPAD-2 (Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication)
Dr. Hakan Çağlıoğlu, Dr. Mustafa Yenerçağ

The AQUATIC Trial (Assessment of Quitting versus Using Aspirin Therapy in Patients with Stabilized Coronary Artery Disease after Stenting Who Require Long-Term Oral Anticoagulation)
Dr. Hakan Çağlıoğlu, Dr. Mustafa Yenerçağ

Baxdrostat in Uncontrolled and Resistant Hypertension
Dr. Kemal Göçer

ICDs in patients with severe LV systolic dysfunction: REFINE-ICD
Dr. Kemal Göçer

REBOOT/BETAMI/DANBLOCK/CAPITAL-RCT: Beta-Blockers after MI with Mildly Reduced EF (an IPD meta-analysis)
Dr. Mehmet Murat Yiğitbaşı

ODYSSEY-HCM: Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
Dr. Mehmet Murat Yiğitbaşı

OPINION trial – 1-year results: Effect of left atrial appendage occlusion during valvular surgery in patients without atrial fibrillation
Dr. Murat Karaçam

TOP-CABG trial – De-escalation of dual antiplatelet therapy provides benefits in patients after coronary artery bypass grafting
Dr. Murat Karaçam

Helicobacter pylori Screening to Prevent Gastrointestinal Bleeding in Patients with Acute Myocardial Infarction (HELP-MI SWEDEHEART) – Design and Rationale of a Cluster Randomized, Crossover, Registry-Based Clinical Trial
Dr. Okan Oğuzhan Ovaz, Dr. Mustafa Yenerçağ

Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy: Rationale and Design of the PARACHUTE-HF Trial
Dr. Okan Oğuzhan Ovaz, Dr. Mustafa Yenerçağ

AMALFI: Active Monitoring for Atrial Fibrillation
Dr. Özkan Karaca

Project MHYH: One-Year Results
Dr. Özkan Karaca

DIGIT-HF: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
Dr. Serkan Bulguroğlu

DOUBLE-CHOICE: Anesthesia Strategies and Self-Expanding Valve Types for TAVI
Dr. Serkan Bulguroğlu

Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled Trial
Dr. Simay Erdal Sayın

Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of Essence-TIMI 73b trial
Dr. Simay Erdal Sayın

Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial
Dr. Şeyma Zeynep Atıcı

Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial)
Dr. Şeyma Zeynep Atıcı

DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalized for Acute Heart Failure
Dr. Yunus Emre Özbebek

Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial
Dr. Yunus Emre Özbebek

TAILORED-CHIP: Tailored antiplatelet therapy for complex high-risk PCI
Dr. Yusuf Uyanık, Dr. Mustafa Yenerçağ

TARGET-FIRST: Early aspirin discontinuation after PCI in acute MI patients
Dr. Yusuf Uyanık, Dr. Mustafa Yenerçağ

 2025 © Turkish Society of Cardiology.